Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126277341 | 12627734 | 1 | I | 2000 | 20160606 | 20160805 | 20160805 | EXP | US-ASTRAZENECA-2016SE61594 | ASTRAZENECA | 44.00 | YR | F | Y | 0.00000 | 20160806 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126277341 | 12627734 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||||
126277341 | 12627734 | 2 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | U | U | 0 | 2 | MG | /wk | ||||||
126277341 | 12627734 | 3 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | U | 0 | TABLET | |||||||||
126277341 | 12627734 | 4 | SS | BRILINTA | TICAGRELOR | 1 | Oral | U | 0 | 90 | MG | TABLET | BID | ||||||
126277341 | 12627734 | 5 | SS | BRILINTA | TICAGRELOR | 1 | Oral | U | 0 | 90 | MG | TABLET | QD | ||||||
126277341 | 12627734 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | OTC | 0 | 325 | MG | TABLET | QD | ||||||
126277341 | 12627734 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Oral | OTC | 0 | 325 | MG | TABLET | QD | ||||||
126277341 | 12627734 | 8 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Oral | OTC | 0 | CHEWABLE TABLET | |||||||||
126277341 | 12627734 | 9 | C | DIPHENHYDRAMINE HYDROCHLORIDE. | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 50 MG, DOSING UNKNOWN, OTC | 0 | TABLET | |||||||||
126277341 | 12627734 | 10 | C | MELATONIN | MELATONIN | 1 | Sublingual | 0 | 5 | MG | TABLET | QD | |||||||
126277341 | 12627734 | 11 | C | MELATONIN | MELATONIN | 1 | Sublingual | OTC | 0 | TABLET | |||||||||
126277341 | 12627734 | 12 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG, DOSING UNKNOWN | 0 | TABLET | |||||||||
126277341 | 12627734 | 13 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 0 | 50 | MG | TABLET | BID | |||||||
126277341 | 12627734 | 14 | C | ALTACE | RAMIPRIL | 1 | Oral | 0 | 5 | MG | CAPSULE | QD | |||||||
126277341 | 12627734 | 15 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 2.5 | MG | TABLET | QD | |||||||
126277341 | 12627734 | 16 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 0 | 12.5 | MG | TABLET | BID | |||||||
126277341 | 12627734 | 17 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 60 | MG | CAPSULE | QD | |||||||
126277341 | 12627734 | 18 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Oral | 0 | 200 | MG | TABLET | BID | |||||||
126277341 | 12627734 | 19 | C | INVOKANA | CANAGLIFLOZIN | 1 | Oral | 0 | 100 | MG | TABLET | QD | |||||||
126277341 | 12627734 | 20 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 50-1000 MG, 1 DF TWO TIMES A DAY WITH MEALS | 0 | TABLET | |||||||||
126277341 | 12627734 | 21 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 0 | 1 | MG | TABLET | TID | |||||||
126277341 | 12627734 | 22 | C | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Subcutaneous | 100 UNIT/ML, 10 UNITS EVERY BEDTIME | 0 | ||||||||||
126277341 | 12627734 | 23 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 20 | MG | TABLET | BID | |||||||
126277341 | 12627734 | 24 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 20 | MG | TABLET | BID | |||||||
126277341 | 12627734 | 25 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 80 | MG | TABLET | BID | |||||||
126277341 | 12627734 | 26 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 80 | MG | TABLET | BID | |||||||
126277341 | 12627734 | 27 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | 150 | UG | TABLET | QD | |||||||
126277341 | 12627734 | 28 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | QD | ||||||||
126277341 | 12627734 | 29 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
126277341 | 12627734 | 30 | C | LOMOTIL | ATROPINE SULFATEDIPHENOXYLATE HYDROCHLORIDE | 1 | Oral | 2.5-0.025 MG, ONCE A DAY PRN | 0 | TABLET | |||||||||
126277341 | 12627734 | 31 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | 75 | MG | CAPSULE | QD | |||||||
126277341 | 12627734 | 32 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | 150 | MG | CAPSULE | BID | |||||||
126277341 | 12627734 | 33 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Oral | 1/2 DAILY | 0 | TABLET | |||||||||
126277341 | 12627734 | 34 | C | MS CONTIN | MORPHINE SULFATE | 1 | Oral | 0 | 30 | MG | PROLONGED-RELEASE TABLET | BID | |||||||
126277341 | 12627734 | 35 | C | MS CONTIN | MORPHINE SULFATE | 1 | Oral | 0 | 30 | MG | PROLONGED-RELEASE TABLET | BID | |||||||
126277341 | 12627734 | 36 | C | NITROGLYCERINE | NITROGLYCERIN | 1 | Transdermal | 0.4 MG/HR, 24 HR | 0 | TRANSDERMAL PATCH | |||||||||
126277341 | 12627734 | 37 | C | NITROSTAT | NITROGLYCERIN | 1 | Sublingual | EVERY 5 MINUTES UPTO 3 TIMES AS NEEDED | 0 | TABLET | |||||||||
126277341 | 12627734 | 38 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 0 | 40 | MEQ | BID | ||||||||
126277341 | 12627734 | 39 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 0 | 20 | MEQ | PROLONGED-RELEASE TABLET | QID | |||||||
126277341 | 12627734 | 40 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Oral | 0 | 12.5 | MG | TABLET | QID | |||||||
126277341 | 12627734 | 41 | C | RANEXA | RANOLAZINE | 1 | Oral | 0 | 500 | MG | PROLONGED-RELEASE TABLET | BID | |||||||
126277341 | 12627734 | 42 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | 75 | MG | QD | ||||||||
126277341 | 12627734 | 43 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | 75 | MG | QD | ||||||||
126277341 | 12627734 | 44 | C | MEDROL | METHYLPREDNISOLONE | 1 | Unknown | 0 | 2 | MG | QD | ||||||||
126277341 | 12627734 | 45 | C | TICLID | TICLOPIDINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126277341 | 12627734 | 1 | Diabetes mellitus |
126277341 | 12627734 | 2 | Diabetes mellitus |
126277341 | 12627734 | 4 | Stent placement |
126277341 | 12627734 | 5 | Stent placement |
126277341 | 12627734 | 6 | Cardiac disorder |
126277341 | 12627734 | 7 | Anticoagulant therapy |
126277341 | 12627734 | 10 | Insomnia |
126277341 | 12627734 | 11 | Insomnia |
126277341 | 12627734 | 15 | Cardiac disorder |
126277341 | 12627734 | 17 | Depression |
126277341 | 12627734 | 21 | Dyskinesia |
126277341 | 12627734 | 23 | Joint swelling |
126277341 | 12627734 | 24 | Cardiac failure congestive |
126277341 | 12627734 | 25 | Joint swelling |
126277341 | 12627734 | 26 | Cardiac failure congestive |
126277341 | 12627734 | 28 | Blood cholesterol abnormal |
126277341 | 12627734 | 29 | Blood cholesterol abnormal |
126277341 | 12627734 | 31 | Neuropathy peripheral |
126277341 | 12627734 | 32 | Neuropathy peripheral |
126277341 | 12627734 | 34 | Arthralgia |
126277341 | 12627734 | 35 | Bone pain |
126277341 | 12627734 | 37 | Chest pain |
126277341 | 12627734 | 38 | Electrolyte depletion |
126277341 | 12627734 | 39 | Electrolyte depletion |
126277341 | 12627734 | 40 | Nausea |
126277341 | 12627734 | 42 | Myocardial infarction |
126277341 | 12627734 | 43 | Stent placement |
126277341 | 12627734 | 44 | Skin disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126277341 | 12627734 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126277341 | 12627734 | Ageusia | |
126277341 | 12627734 | Arterial occlusive disease | |
126277341 | 12627734 | Arterial spasm | |
126277341 | 12627734 | Arthralgia | |
126277341 | 12627734 | Bone pain | |
126277341 | 12627734 | Contusion | |
126277341 | 12627734 | Diarrhoea | |
126277341 | 12627734 | Drug hypersensitivity | |
126277341 | 12627734 | Dyskinesia | |
126277341 | 12627734 | Fall | |
126277341 | 12627734 | Gastric hypomotility | |
126277341 | 12627734 | Glycosylated haemoglobin increased | |
126277341 | 12627734 | Hypophagia | |
126277341 | 12627734 | Intentional product misuse | |
126277341 | 12627734 | Middle ear effusion | |
126277341 | 12627734 | Orthostatic hypotension | |
126277341 | 12627734 | Thinking abnormal | |
126277341 | 12627734 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126277341 | 12627734 | 1 | 2010 | 2010 | 0 | |
126277341 | 12627734 | 2 | 20151228 | 0 | ||
126277341 | 12627734 | 4 | 20160325 | 0 | ||
126277341 | 12627734 | 5 | 20160412 | 201604 | 0 | |
126277341 | 12627734 | 6 | 1998 | 0 | ||
126277341 | 12627734 | 7 | 1998 | 0 | ||
126277341 | 12627734 | 8 | 20150702 | 0 | ||
126277341 | 12627734 | 9 | 20150702 | 0 | ||
126277341 | 12627734 | 10 | 20150702 | 0 | ||
126277341 | 12627734 | 11 | 20150702 | 0 | ||
126277341 | 12627734 | 12 | 20150708 | 0 | ||
126277341 | 12627734 | 13 | 20151228 | 0 | ||
126277341 | 12627734 | 14 | 20151228 | 0 | ||
126277341 | 12627734 | 15 | 20151228 | 0 | ||
126277341 | 12627734 | 16 | 20151228 | 0 | ||
126277341 | 12627734 | 17 | 2010 | 0 | ||
126277341 | 12627734 | 18 | 20160316 | 0 | ||
126277341 | 12627734 | 19 | 20160302 | 0 | ||
126277341 | 12627734 | 20 | 20151228 | 0 | ||
126277341 | 12627734 | 21 | 2007 | 0 | ||
126277341 | 12627734 | 22 | 20151228 | 0 | ||
126277341 | 12627734 | 23 | 1980 | 0 | ||
126277341 | 12627734 | 24 | 1980 | 0 | ||
126277341 | 12627734 | 25 | 1998 | 0 | ||
126277341 | 12627734 | 26 | 1998 | 0 | ||
126277341 | 12627734 | 27 | 20151228 | 0 | ||
126277341 | 12627734 | 28 | 1992 | 0 | ||
126277341 | 12627734 | 29 | 20151228 | 0 | ||
126277341 | 12627734 | 30 | 20160307 | 0 | ||
126277341 | 12627734 | 31 | 2015 | 0 | ||
126277341 | 12627734 | 32 | 20151228 | 0 | ||
126277341 | 12627734 | 33 | 20160307 | 0 | ||
126277341 | 12627734 | 34 | 2006 | 0 | ||
126277341 | 12627734 | 35 | 2006 | 0 | ||
126277341 | 12627734 | 36 | 20160307 | 0 | ||
126277341 | 12627734 | 37 | 20160328 | 0 | ||
126277341 | 12627734 | 38 | 1980 | 0 | ||
126277341 | 12627734 | 39 | 20160111 | 0 | ||
126277341 | 12627734 | 40 | 20160309 | 0 | ||
126277341 | 12627734 | 41 | 20160215 | 0 | ||
126277341 | 12627734 | 44 | 1997 | 0 |